mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.leukres.2016.11.014PMID 28038356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic Lymphocytic Leukemia

  2019cited by this paper
• mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients

  2016cited by this paper
• HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment.

  2016cited by this paper
• Accumulation of adverse prognostic markers worsens prognosis in chronic lymphocytic leukaemia

  2015cited by this paper
• Metabolic plasticity in CLL: adaptation to the hypoxic niche

  2015cited by this paper
• SOX11 expression in chronic lymphocytic leukemia correlates with adverse prognostic markers

  2015cited by this paper
• Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic Leukemia

  2015cited by this paper
• KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia.

  2015cited by this paper
• Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.

  2014cited by this paper
• HLA-G Expression as a Prognostic Indicator in B-Cell Chronic Lymphocytic Leukemia

  2014cited by this paper
• Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go

  2014cited by this paper
• How the microenvironment wires the natural history of chronic lymphocytic leukemia.

  2014cited by this paper
• The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies.

  2014cited by this paper
• Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia

  2014cited by this paper
• Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients

  2014cited by this paper
• DNA methylation as a biomarker for the detection of hidden carcinoma in endometrial atypical hyperplasia.

  2014cited by this paper
• BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 Proteins Are Related to Human Glioma Tumor Grade: Immunohistochemistry and Public Microarray Data Meta-Analysis

  2013cited by this paper
• Molecular biomarkers in chronic lymphocytic leukemia.

  2013cited by this paper
• SF3B1 mutations in chronic lymphocytic leukemia.

  2013cited by this paper
• Hypoxia-inducible factor-1α expression indicates poor prognosis in myelodysplastic syndromes

  2012cited by this paper
• The updated biology of hypoxia‐inducible factor

  2012cited by this paper
• Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.

  2012cited by this paper
• Regulation of CLL survival by hypoxia‐inducible factor and its target genes

  2012cited by this paper
• Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.

  2012cited by this paper
• Chronic lymphocytic leukemia: prognostic factors and impact on treatment.

  2011cited by this paper
• The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker.

  2011cited by this paper
• Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1→HIF-1α pathway

  2011cited by this paper
• Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma.

  2011cited by this paper
• Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2011cited by this paper
• Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia.

  2011cited by this paper
• Expression of Hypoxia-inducible factor 1-α and Vascular endothelial growth factor–C in locally advanced breast cancer patients

  2011cited by this paper
• Prognostic implications of hypoxia-inducible factor-1α in epidermal growth factor receptor-negative non-small cell lung cancer.

  2011cited by this paper
• Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells.

  2009cited by this paper
• Analyzing real-time PCR data by the comparative CT method

  2008cited by this paper
• New prognostic markers in chronic lymphocytic leukemia.

  2008cited by this paper
• Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up.

  2008cited by this paper
• Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

  2008cited by this paper
• Dysregulated angiogenesis in B-chronic lymphocytic leukemia: Morphologic, immunohistochemical, and flow cytometric evidence

  2008cited by this paper
• Recent advances in the diagnosis and therapy of richter’s syndrome

  2007cited by this paper
• Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia.

  2006cited by this paper
• Genetic abnormalities and clinical outcome in chronic lymphocytic leukemia.

  2006cited by this paper
• In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.

  2005cited by this paper
• X-Tile

  2004cited by this paper
• Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF

  2004cited by this paper
• ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

  2003cited by this paper
• Biological and Clinical Heterogeneity of B-cell Chronic Lymphocytic Leukemia

  2003cited by this paper
• CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

  2002cited by this paper
• Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non‐Hodgkin's lymphoma

  2002cited by this paper
• Hypoxia — a key regulatory factor in tumour growth

  2002cited by this paper
• Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis.

  2001cited by this paper
• Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.

  2001cited by this paper
• Expression of hypoxia‐inducible factor–1α in oligodendrogliomas

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia

  2000cited by this paper
• Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

  1999cited by this paper
• A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

  1981cited by this paper
• Clinical staging of chronic lymphocytic leukemia.

  1975cited by this paper

• Upregulation of Genetic Markers of Poor Prognosis following Chemotherapy in Acute Myeloid Leukemia Cells

  2026cites this paper
• The hypoxia signaling pathway in the development of acute myeloid leukemia.

  2025cites this paper
• MiR-155 deficiency and hypoxia results in metabolism switch in the leukemic B-cells

  2024cites this paper
• In-vitro Modulation of mTOR-HIF-1α Axis by TLR7/8 Agonist (Resiquimod) in B-Chronic Lymphocytic Leukemia

  2023cites this paper
• Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system

  2023cites this paper
• Investigation into the Role of Long-Non-Coding RNA MIAT in Leukemia

  2023cites this paper
• Hypoxic stress and hypoxia-inducible factors in leukemias

  2022cites this paper
• M2PP: a novel computational model for predicting drug-targeted pathogenic proteins

  2022cites this paper
• Network Pharmacology and Molecular Docking Approach to Reveal the Immunotherapeutic Mechanism of Cuscutae Semen in Treating Thin Endometrium

  2022cites this paper
• Combined Effects of 2-Methoxyestradiol (Hypoxia-Inducible Factor 1α Inhibitor) and Dasatinib (A Second-Generation Tyrosine Kinase Inhibitor) on Chronic Myelocytic Leukemia Cells

  2022cites this paper
• A 3′ tRNA‐derived fragment produced by tRNALeuAAG and tRNALeuTAG is associated with poor prognosis in B‐cell chronic lymphocytic leukemia, independently of classical prognostic factors

  2021cites this paper
• Breakthrough Science: Hypoxia-Inducible Factors, Oxygen Sensing, and Disorders of Hematopoiesis.

  2021cites this paper
• The Tumor Microenvironment-Dependent Transcription Factors AHR and HIF-1α Are Dispensable for Leukemogenesis in the Eµ-TCL1 Mouse Model of Chronic Lymphocytic Leukemia

  2021cites this paper
• HIF-1฀ is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia

  2021cites this paper
• PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1

  2020cites this paper
• Low expression of miR-20b-5p indicates favorable prognosis in laryngeal squamous cell carcinoma, especially in patients with non-infiltrated regional lymph nodes.

  2020cites this paper
• HIF-1α is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia

  2019cites this paper
• Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.

  2019cites this paper
• HIF-1a is overexpressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia

  2019cites this paper
• Identification of a novel, internal tRNA-derived RNA fragment as a new prognostic and screening biomarker in chronic lymphocytic leukemia, using an innovative quantitative real-time PCR assay.

  2019cites this paper
• HIF-α factors as potential therapeutic targets in leukemia

  2018cites this paper
• Quantitative analysis and study of the mRNA expression levels of apoptotic genes BCL2, BAX and BCL2L12 in the articular cartilage of an animal model of osteoarthritis.

  2018cites this paper
• Non-coding RNAs: the riddle of the transcriptome and their perspectives in cancer.

  2018cites this paper
• Elevated miR-20b-5p expression in peripheral blood mononuclear cells: A novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia.

  2018cites this paper
• Expression of hypoxia-inducible factor-1a predicts benefit from rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in diffuse large B-cell lymphoma.

  2018cites this paper
• Alternative Splicing Detection Tool-a novel PERL algorithm for sensitive detection of splicing events, based on next-generation sequencing data analysis.

  2018cites this paper
• MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia

  2018influential citation
• Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?

  2018cites this paper
• Metabolic underpinnings of leukemia pathology and treatment

  2018cites this paper
• MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis

  2017cites this paper